ClinicalTrials.govpublic full text
Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers
tuberculosis, tuberculosis, pulmonary, anti-infective agents, anti-bacterial agents, rifampin, rifapentine, midazolam, molecular mechanisms of pharmacological action, antitubercular agents, pharmacologic actions, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 852869
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.